跳轉至內容
Merck
全部照片(1)

文件

P7791

Sigma-Aldrich

哌唑嗪 盐酸盐

≥99.0% (HPLC), powder, α1-adrenoceptor antagonist

同義詞:

1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-4-(2-呋喃甲酰基)哌嗪 盐酸盐, 脉宁平 盐酸盐

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C19H21N5O4 · HCl
CAS號碼:
分子量::
419.86
Beilstein:
4303561
EC號碼:
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

product name

哌唑嗪 盐酸盐, ≥99.0% (HPLC)

化驗

≥99.0% (HPLC)

形狀

powder

溶解度

H2O: 0.5 mg/mL
methanol: 6 mg/mL
dilute aqueous acid: insoluble

SMILES 字串

Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4

InChI

1S/C19H21N5O4.ClH/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22);1H

InChI 密鑰

WFXFYZULCQKPIP-UHFFFAOYSA-N

基因資訊

尋找類似的產品? 前往 產品比較指南

一般說明

哌唑嗪是一种α-肾上腺素能阻滞剂。它被视为一种周围血管舒张抗高血压药物。哌唑嗪是喹唑啉的衍生物。

應用

盐酸哌唑嗪已用于:
  • 阻断介导小鼠交感血管收缩的 α1 肾上腺素能受体
  • 作为 α1-肾上腺素受体阻滞剂,大鼠灌胃给药
  • 作为血管扩张剂,与胰岛素一起注入小鼠左心室,评价其对肾功能的影响

生化/生理作用

外周 α1-肾上腺素能受体拮抗剂;血管扩张剂。哌唑嗪可用于治疗慢性创伤后应激障碍(PTSD)。它通过舒张血管起降血压作用,因此可用于治疗高血压。

特點和優勢

该化合物在《受体分类和信号转导手册》的α1-肾上腺素受体α2-肾上腺素受体褪黑激素页面上进行了描述。想要浏览手册的其他页面, 请单击此处
这种化合物是 ADME 毒性和神经科学研究的特色产品。发现更多特色 ADME 毒性神经科学产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

包裝

无底玻璃瓶。内含物装在插入的融合锥内。

注意

吸湿;光敏感。

象形圖

Health hazardExclamation mark

訊號詞

Warning

危險聲明

危險分類

Repr. 2 - STOT RE 2 - STOT SE 3

標靶器官

Central nervous system

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Enhanced salt sensitivity following shRNA silencing of neuronal TRPV1 in rat spinal cord
Yu S Q and Wang D H
Acta Pharmacologica Sinica, 32(6), 845-845 (2011)
Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis
Lim Y K, et al.
Kidney International, 58(3), 1033-1044 (2000)
Stal Saurav Shrestha et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 55(1), 141-146 (2014-01-05)
The PET radioligand (11)C-CUMI-101 was previously suggested as a putative agonist radioligand for the serotonin 1A (5-hydroxytryptamine 1A [5-HT1A]) receptor in recombinant cells expressing human 5-HT1A receptor. However, a recent study showed that CUMI-101 behaved as a potent 5-HT1A receptor
Murray A Raskind et al.
The American journal of psychiatry, 170(9), 1003-1010 (2013-07-13)
The authors conducted a 15-week randomized controlled trial of the alpha-1 adrenoreceptor antagonist prazosin for combat trauma nightmares, sleep quality, global function, and overall symptoms in active-duty soldiers with posttraumatic stress disorder (PTSD) returned from combat deployments to Iraq and
Nia C S Lewis et al.
American journal of physiology. Regulatory, integrative and comparative physiology, 304(2), R147-R154 (2012-11-24)
We examined the hypothesis that α(1)-adrenergic blockade would lead to an inability to correct initial orthostatic hypotension (IOH) and cerebral hypoperfusion, leading to symptoms of presyncope. Twelve normotensive humans (aged 25 ± 1 yr; means ± SE) attempted to complete

文章

Gain a deeper understanding of the various types of receptor agonists and antagonists, including full, partial, and inverse agonists and competitive/reversible and non-competitive/irreversible antagonists.

Review alpha 1 adrenoceptors as well as their agonists, antagonists, and tissue expression patterns. We suggest several modulators and alternatives for working with a-1 adrenoreceptors.

Learn about alpha-2 adrenoceptor and its subtypes, mediated responses, and applications of agonists. Included is a list of available products and a comparison table.

Discover Bioactive Small Molecules for ADME/Tox

查看全部

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務